The Global Tribune

Creative Bioarray Introduces Advanced FISH Probe to Detect 2019 Novel Coronavirus

 Breaking News
  • No posts were found

Creative Bioarray Introduces Advanced FISH Probe to Detect 2019 Novel Coronavirus

March 10
23:18 2020

The current 2019 Novel Coronavirus outbreaks have triggered a major global health crisis, and to help improve the global capacity to detect the novel coronavirus, Creative Bioarray offers 2019 Novel Coronavirus Detection FISH Probes.

At the beginning of 2019, an ongoing outbreak of a novel coronavirus (SARS-CoV-2) has raised global concerns. It is identified as the cause of pneumonia with unknown etiology. Since the early outbreak in Wuhan, China, it has subsequently spread to all provinces of China and many other countries. With an unrelenting drive in bio-scientific research and industry, Creative Bioarray has developed 2019 Novel Coronavirus Detection FISH Probe to help expedite the response to this outbreak.

At present, the detection of SARS-CoV-2 mainly relies on nucleic acid detection, which requires a higher level of detection equipment, laboratory standards and operators, thus it is difficult for general hospitals to complete. Therefore, the establishment of fast and accurate specific detection methods is of great significance for controlling the epidemic.

In Site Hybridization (ISH) is able to identify viral particles in infected cells, and provides both accurate molecular detection and visualization of infected cell types and tissues. Fluorescence in situ hybridization (FISH), developed in the 1980s, is a cytogenetic technique using fluorescent probes to bind the chromosome with a high degree of complementarity. It is a powerful and easy method to detect RNA or DNA sequences in cells, tissues, and tumors.

The novel coronavirus (SARS-CoV-2) in 2019 is a single-stranded RNA coronavirus. Based on the known genomic data, the probe sequence is designed, and the probe is directly labeled with fluorescein. RNA-FISH technology can be used to locate and semi-quantify SARS-CoV-2. Fluorescence in situ hybridization can be used to detect the distribution and expression of SARS-CoV-2 in different tissues of the human body, such as heart, liver, spleen, lung, kidney, etc.

Empowered by leading technology and years of experience in biomedical science, Creative Bioarray offers 2019 Novel Coronavirus Detection FISH Probe to help improve the global capacity to detect and respond to the 2019 novel coronavirus. This FISH Probe has the following advantages:

 Simple and fast to operate
 Highly specific and sensitive
 Stable performance with a shelf life of up to 1 year
 Strong fluorescence signal and intuitive results
 Accurate positioning without experimental pollution

Apart from the 2019 Novel Coronavirus Detection FISH Probe, Creative Bioarray provides the most comprehensive list of FISH probes for rapid identification of a wide range of chromosomal aberrations across the genome. Chromosome Probes, Detection Probes, Animal Probes, Bacteria Probes, microRNA Probes, ISH Probes are all available, targeting relevant regions for a wide range of applications such as detection of gene amplification, deletion, translocation and chromosomal aneuploidies associated with tumor and genetic disease profiling.

Supported by in-house scientists and first-in-class technological platforms, Creative Bioarray spares no effort to provide customized, standardized and reliable services and products. More information can be found on

About Creative Bioarray

Recognized as the leading custom service provider with extensive experience in various biological fields, Creative Bioarray, offering a comprehensive range of Cell Services, Biosample Services and Histology Services, is an innovative biotechnology company whose mission focuses on developing unique technologies that provide global scientists to facilitate the investigation of life science researches.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-619-7922
Country: United States